Advertisement
Canada markets close in 4 hours 37 minutes
  • S&P/TSX

    21,874.47
    -137.25 (-0.62%)
     
  • S&P 500

    5,058.37
    -12.18 (-0.24%)
     
  • DOW

    38,348.76
    -154.93 (-0.40%)
     
  • CAD/USD

    0.7288
    -0.0033 (-0.45%)
     
  • CRUDE OIL

    82.56
    -0.80 (-0.96%)
     
  • Bitcoin CAD

    88,999.45
    -2,461.85 (-2.69%)
     
  • CMC Crypto 200

    1,406.76
    -17.34 (-1.22%)
     
  • GOLD FUTURES

    2,345.80
    +3.70 (+0.16%)
     
  • RUSSELL 2000

    1,990.59
    -12.05 (-0.60%)
     
  • 10-Yr Bond

    4.6500
    +0.0520 (+1.13%)
     
  • NASDAQ

    15,706.95
    +10.31 (+0.07%)
     
  • VOLATILITY

    16.11
    +0.42 (+2.68%)
     
  • FTSE

    8,033.48
    -11.33 (-0.14%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6815
    -0.0021 (-0.31%)
     

Factors Setting the Tone for Lowe's (LOW) in Q3 Earnings

Lowe's Companies, Inc. LOW is scheduled to report third-quarter fiscal 2019 numbers on Nov 20, before the opening bell.

In the last reported quarter, the company recorded a positive earnings surprise of 7.5%. Further, its bottom line beat estimates by 1.6%, on average, over the trailing four quarters.

The Zacks Consensus Estimate for fiscal third-quarter earnings is pegged at $1.34, indicating rise of 28.9% from $1.04 reported in the year-ago quarter. However, the consensus mark was unchanged in the last 30 days. For revenues, the consensus estimate is pegged at $17,714 million, suggesting an increase of 1.7% from the year-ago quarter’s reported figure.

Lowe's Companies, Inc. Price and EPS Surprise

 

Lowe's Companies, Inc. Price and EPS Surprise
Lowe's Companies, Inc. Price and EPS Surprise

Lowe's Companies, Inc. price-eps-surprise | Lowe's Companies, Inc. Quote

ADVERTISEMENT

Key Factors to Note

Gains from the Pro business have been driving Lowe's performance. Additionally, sales growth initiatives — including better product presentation, in-store merchandising and enhancing digital presence — have been driving the company’s sales and comparable store sales (comps).

In a bid to continue augmenting sales from Pro customers, it has been boosting Pro-focused brands. Lowe’s has also revamped its Pro-service business website, LowesForPros.com, to give special attention to the needs of its Pro customers. Moreover, management’s focus on improving omni-channel capabilities, enhancing consumers’ digital shopping experience and rationalizing inventory has been working in its favor. We expect the benefits from these initiatives to get reflected in the top line and comps in third-quarter fiscal 2019.

However, the company has been grappling with softness in the margins, stemming from an increase in supply-chain costs. Further, higher customer delivery expenses, adverse product mix shift and inventory shrinks are expected to have weighed on the company’s margins in the fiscal third quarter.

Nonetheless, Lowe’s is undertaking necessary pricing and other actions to battle cost-related headwinds. These efforts might have slightly cushioned the bottom line in the quarter under review.

Zacks Model

Our proven model predicts an earnings beat for Lowe’s this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Lowe’s has a Zacks Rank #2 and an Earnings ESP of +1.62%.

Other Stocks With Favorable Combination

Walmart Inc WMT currently has an Earnings ESP of +2.45% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

Dollar General Corporation DG has an Earnings ESP of +2.34% and a Zacks Rank #2 at present.

Ross Stores, Inc ROST currently has an Earnings ESP of +4.03% and a Zacks Rank #2.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Lowe's Companies, Inc. (LOW) : Free Stock Analysis Report
 
Dollar General Corporation (DG) : Free Stock Analysis Report
 
Ross Stores, Inc. (ROST) : Free Stock Analysis Report
 
Walmart Inc. (WMT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research